Brief: WntResearch: positive results from clinical study with drug candidate Foxy-5

Opsy Holding AB

21/03/2017 12:47

March 21 (Reuters) - WntResearch AB  WNT.ST : 
    * Says has obtained positive results from the analyses of 
patient tumour tissue samples before and after treatment in a 
Phase 1b study with Foxy-5 - a drug candidate intended to 
inhibit tumours from spreading in cancer patients 
    * Based on the obtained results, the company has defined the 
dose level for the upcoming Phase 2 study, which was one of the 
objectives with this clinical study 
 
     
 Source text: http://bit.ly/2nZMFbs 
     
 Further company coverage:  WNT.ST   
    
 
 
 (Gdynia Newsroom) 
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))